Samuel Sekuritas sells 18.30 million RLCO shares, reducing stake to 11.85%
PT Samuel Sekuritas Indonesia reduced its stake in PT Abadi Lestari Indonesia Tbk (RLCO) from 12.44% to 11.85% by selling 18.30 million shares. The sale appeared in the Indonesia Stock Exchange's November 6, 2026, report on ownership changes involving shareholders with stakes above 5%, alongside a new fund investment in Prodia.

RLCO's IPO and business
Samuel Sekuritas had served as the sole underwriter of RLCO's initial public offering on a full-commitment basis, according to BCA Sekuritas (IQPlus). RLCO is the company behind RealCo, a swallow's nest product brand from Bojonegoro, East Java.
The company made its stock market debut on December 8, 2025, becoming the exchange's 25th new issuer that year. Its offering of 625 million shares, representing 20% of paid-up capital, raised Rp105 billion at Rp168 per share and put its market capitalization at about Rp525 billion, according to Kompas.id.
Nearly 520,000 investors participated in the offering, a record for Indonesia's e-IPO system, Kompas.id reported. The IPO was oversubscribed 143.19 times.
RLCO said it planned to use 56.33% of the proceeds remaining after issuance costs as working capital to buy bird's-nest raw materials. It would contribute the other 43.67% as additional capital to subsidiary PT Realfood Winta Asia for raw-material purchases.
Processed bird's nest accounts for 88% of RealCo's sales, with the remaining 12% coming from other protein-based consumer products, including high-protein chicken broth, according to Kompas.id. Exports represent about 89% of sales and the domestic market 11%. Revenue increased from Rp379.45 billion in 2022 to Rp530.38 billion in 2024.
Henan fund takes 5.05% of Prodia
Reksa Dana Syariah Henan Ekuitas Syariah Berkah became a new shareholder in clinical laboratory operator PT Prodia Widyahusada Tbk (PRDA), acquiring 47.34 million shares for a 5.05% stake.
The fund is managed by PT Henan Putihrai Asset Management. According to Investor Trust, the manager reported Rp13 trillion in assets under management and more than 110,000 investors as of May 2026. It also received two Best Sharia Awards 2026 on October 29 for its sharia equity funds' performance over three-year and five-year periods.
Another healthcare investment in the ownership report involved PT Sarana Meditama Metropolitan Tbk (SAME), an Emtek subsidiary. It purchased 318,000 shares of PT Nitrasanata Dharma Tbk (JECX), leaving it with a 35.75% holding in the Jakarta Eye Center hospital operator.
Fidelity cuts Arwana holding and adds Dharma Polimetal shares
Luxembourg-based Fidelity Funds reduced its investment in ceramic producer PT Arwana Citramulia Tbk (ARNA) while buying shares in automotive component manufacturer PT Dharma Polimetal Tbk (DRMA).
The sale of 886,700 ARNA shares lowered Fidelity's stake from 7.39% to 7.38%. Its purchase of 62,600 DRMA shares left it holding about 5.03% of the Triputra Group company.
DRMA reported first-quarter 2026 revenue of Rp1.5 trillion, a 6% increase from a year earlier, and net profit of Rp144.9 billion, up 1.5%, according to IDNFinancials. The company is targeting revenue growth of around 10% for the full year.
MR.D.I.Y. shareholder adds shares; Morgan Stanley reduces FILM stake
MDIH (Singapore) Pte. Ltd. bought another 150,000 shares of household goods retailer PT Daya Intiguna Yasa Tbk (MDIY). The majority shareholder's holding stood at approximately 35.60%.
The retailer, which operates as MR.D.I.Y. Indonesia, reported revenue of Rp7.2 trillion for the first nine months of 2026, up 24.5% year over year. Profit after tax increased 12.9% to Rp894.3 billion, according to a company press release.
MR.D.I.Y. Indonesia had opened 202 stores so far in 2026, taking its network to 1,416 locations across 37 provinces. Its full-year target is at least 270 new stores.
In the production sector, Morgan Stanley and Co International Plc sold 75,000 shares of PT MD Pictures Tbk (FILM), slightly reducing its stake to 10.47%.
